Larvol Delta - VIRTUAL-BDTX1535-a-CNS-penetrant-MasterKey-inhibitor-of-common-uncommon-and-resistant-EGFR-mutations-demonstrates-in-vivo-efficacy-and-has-potential-to-treat-osimertinibresistant-NSCLC-with-or-without-brain-metastases

Tagrisso (osimertinib) - AstraZeneca

BDTX-1535 - Black Diamond Therap

https://www.aacr.org/meeting/aacr-nci-eortc-international-conference-on-molecular-targets-and-cancer-therapeutics/program/

Matthew C. Lucas

Sep 30, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next